Cutaneous porphyria in a neonate with tyrosinaemia type 1

被引:0
|
作者
Serge Vanden Eijnden
Denise Blum
Anne Clercx
Philippe Goyens
Corine De Laet
Esther Vamos
机构
[1] Neonatal Intensive Care Unit,
[2] University Hospital for Children Queen Fabiola,undefined
[3] Université Libre de Bruxelles (U.L.B.),undefined
[4] 15 av. J.J.Crocq,undefined
[5] 1020 Brussels,undefined
[6] Belgium e-mail: svdeijnd@ulb.ac.be Tel.: +32-2-4773250,undefined
[7] Fax: +32-2-4773295 ,undefined
[8] Department of Paediatrics,undefined
[9] University Hospital for Children Queen Fabiola,undefined
[10] Brussels,undefined
[11] Belgium,undefined
[12] Department of Medical Genetics,undefined
[13] University Hospital for Children Queen Fabiola,undefined
[14] Brussels,undefined
[15] Belgium,undefined
来源
关键词
Key words Photosensitivity; Porphyria; Tyrosinaemia type 1; NTBC; Bronze baby syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
A term infant born to consanguineous parents presented at birth with hypoglycaemia, thrombocytopenia, coagulopathy and hyperbilirubinaemia associated with polycythaemia due to delayed cord clamping. Despite phototherapy and correction of polycythaemia by partial exchange transfusion, coagulopathy, hypoglycaemia and conjugated hyperbilirubinaemia persisted, suggesting hepatic failure. Metabolic work-up led to the diagnosis of tyrosinaemia type 1 on day 4. Two – (2-nitro-4-trifluoromethylbenzoyl) – 1,3 cyclohexanedione (NTBC) treatment, started on day 5, resulted in progressive clinical improvement and unambiguous biochemical response. Severe skin purpuric lesions occurred in areas exposed to phototherapy. These resolved slowly after its discontinuation. Urine analysis sampled just before and 6 days after starting NTBC treatment showed high levels of type 1 coproporphyrin isomers. Such findings do not seem directly related to tyrosinaemia type 1 where succinylacetone inhibits δ-aminolevulinic acid (δ-ALA) dehydratase and where the accumulation of δ-ALA results in neurotoxicity without photosensitivity.
引用
收藏
页码:503 / 506
页数:3
相关论文
共 50 条
  • [41] TYROSINAEMIA TYPE 1: NATURAL PROTEIN TOLERANCE INCREASES WITH AGE
    Daly, A.
    Neville, C.
    McKiernan, P.
    MacDonald, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S172 - S172
  • [42] Mutation screening for tyrosinaemia type I
    Heath, SK
    Gray, RGF
    McKiernan, P
    Au, KM
    Walker, E
    Green, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 2002, 25 (06) : 523 - 524
  • [43] Two siblings with tyrosinaemia type 2
    Ömer Aydin
    Pelin Zorlu
    Benal Kunak
    Tahsin Tezic
    Alev Eken
    European Journal of Pediatrics, 2003, 162 : 81 - 83
  • [44] Fumarylacetoacetase mutations in tyrosinaemia type I
    Rootwelt, H
    Hoie, K
    Berger, R
    Kvittingen, EA
    HUMAN MUTATION, 1996, 7 (03) : 239 - 243
  • [45] EVALUATION OF SUCCINYLACETONE ANALYSIS AS A NEWBORN SCREENING TEST FOR TYROSINAEMIA TYPE 1
    Dowden, S.
    Webster, R.
    Johnston, C.
    Stokes, G.
    Preece, M. A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S158 - S158
  • [46] Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1
    De Laet, Corinne
    Munoz, Vanessa Terrones
    Jaeken, Jaak
    Francois, Baudouin
    Carton, Dietbrandt
    Sokal, Etienne M.
    Dan, Bernard
    Goyens, Philippe J.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (10): : 962 - 964
  • [47] CUTANEOUS HEPATIC PORPHYRIA - PORPHYRIA CUTANEA-TARDA
    TOPI, GC
    PIMSTONE, NR
    MOLECULAR ASPECTS OF MEDICINE, 1990, 11 (1-2) : 67 - 71
  • [48] Liver transplantation in tyrosinaemia type I
    Baumann, U
    Rodeck, B
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (10) : 1102 - 1106
  • [49] Two siblings with tyrosinaemia type 2
    Aydin, ÖF
    Zorlu, P
    Kunak, B
    Tezic, T
    Eken, A
    EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (02) : 81 - 83
  • [50] Cutaneous aspergillosis in a neonate
    Gupta, M
    Weinberger, B
    WhitleyWilliams, PN
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (05) : 464 - 465